Ramipril research papers are retracted over faked dataBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5035 (Published 21 September 2015) Cite this as: BMJ 2015;351:h5035
- Michael McCarthy
Two papers that reported that the blood pressure drug ramipril was beneficial in patients with intermittent claudication due to peripheral artery disease have been retracted after an investigation found that data were fabricated by the studies’ lead author, Anna A Ahimastos, a researcher at the prestigious Baker IDI Heart and Diabetes Institute in Melbourne, Australia.
The first paper,1 published in JAMA in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial